RNA Interference: Optimizing the Potential of RNAi as a Drug Discovery Research Tool: Expediting Target Identification and Validation

November 17 - 18, 2003
Kingsway Hall Hotel
Central London (UK)
Contact: EF International

Cenix Participant:

Dr. Christophe Echeverri (CEO/CSO)
(Scientific Advisory Board of the Conference and Chairman of Day 1)
"Genome-based RNAi Screening in Multiple Organisms: Results from Genome-Wide and Focused Screens in C. elegans, Drosophila and Human Cells"

Monday, November 17, 2003, 10:50 am